[Application monitoring of the use of sorafenib in papillary renal cell carcinoma]

Urologe A. 2007 Sep;46(9):1291. doi: 10.1007/s00120-007-1500-9.
[Article in German]
No abstract available

Publication types

  • Multicenter Study

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / adverse effects
  • Benzenesulfonates / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / immunology
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / immunology
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / adverse effects
  • Pyridines / therapeutic use*
  • Signal Transduction / drug effects
  • Sorafenib
  • T-Lymphocytes, Regulatory / drug effects
  • T-Lymphocytes, Regulatory / immunology
  • Tumor Escape / drug effects
  • Tumor Escape / immunology

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib